The Oxford vaccine could be approved within days - and experts say it’s a ‘game changer’

This article contains affiliate links. We may earn a small commission on items purchased through this article, but that does not affect our editorial judgement.

AstraZeneca CEO, Pascal Soriot, has told the Sunday Times that he believes researchers have found “the winning formula” by using two doses of the vaccine, and promised to publish the results, as reports suggest that the UK regulator could approve the injection within days.

Soriot said, “We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else. I can’t tell you more because we will publish at some point.”

‘Look promising’

According to the Sunday Telegraph, the UK could roll out the Oxford/AstraZeneca vaccine from 4 January, according to plans drawn up by ministers.

The UK government has ordered 100 million doses of the vaccine, with around 40 million expected to be available by the end of March.

Dr Peter Openshaw, professor of experimental medicine at Imperial College London, said, “It looks really promising and it also looks very deliverable.

“We have huge optimism that this is a major part of how we can control the current surge.”